NRC Health (NRC) income statement
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3078% above fair value
$26.16+0.27 (+1.06%)
Close on Nov 18, 2026Market cap $578.65MP/E –Yield 1.99%
NRC Health income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- 10.5%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 0.65
- Debt to equity
- 13.75
- Debt to assets
- 66.1%
- Cash to current liabilities
- 9.5%
Valuation
- P/E ratio
- –
- Price to sales
- 4.13
- Price to book
- 88.36
- Dividend yield
- 1.99%
See a number that looks wrong?